Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Myelodysplastic Syndromes 9Lymphoma, Non-Hodgkin 7Leukemia 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Hematologic Neoplasms 5Congenital Abnormalities 4Breast Neoplasms 4Neuroblastoma 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Blast Crisis 3Anemia, Refractory, with Excess of Blasts 3Wilms Tumor 2Testicular Neoplasms 2Sarcoma 2Rhabdomyosarcoma 2Retinoblastoma 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Medulloblastoma 2Liver Neoplasms 2Kidney Neoplasms 2Hepatoblastoma 2Graft vs Host Disease 2Desmoplastic Small Round Cell Tumor 2Central Nervous System Neoplasms 2Astrocytoma 2

Interventions

pazopanib 2thymoglobulin 1sapanisertib 1pexidartinib 1pembrolizumab 1fludarabine phosphate 1Trabectedin 1Thiotepa 1Tacrolimus 1Stem Cell Transplantation 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Polymerase Chain Reaction 1Neoadjuvant Therapy 1Mycophenolic Acid 1Melphalan 1Imatinib Mesylate 1Gene Expression Profiling 1Etoposide 1Doxorubicin 1Docetaxel 1Cyclosporins 1Cyclosporine 1Blotting, Western 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neurofibrosarcoma × Thiotepa × Clear all
NCT04530487 2025-06-29

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 7 charts
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Neurofibrosarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡